Siga Technologies Inc (SIGA) Stock Price, Quote & News

Company Profile

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 212 672 9100

Website: www.siga.com

Address:

31 East 62nd Street, New York, United States

TJCaz Apr. 26 at 2:08 PM

$SIGA I see that Schwab has this stock at Outperform, current as of 4/24/26. Every indicator is negative, PE, all projections for '26, and no other analysts are following that I can find. Why would Schwab rate it an A if there is no reason to? I just noticed this stock and am looking for a reason...even if to just doubt Schwab's reliability. Monkeypox regional approval and an open BARDA contract can't be enough to warrant such a high grade. Right? Anyone with a supporting fact out there?

1 · Reply

ComradeKomisar Apr. 23 at 8:11 PM

$SIGA 🤔

1 · Reply

petsaregood71 Apr. 23 at 11:07 AM

$SIGA https://www.futuremarketinsights.com/reports/monkeypox-treatment-market

0 · Reply

Jonnystar Apr. 22 at 1:09 PM

$SIGA time to buy

0 · Reply

petsaregood71 Apr. 21 at 8:02 PM

$SIGA OFF GOOG AI--As of April 2026, SIGA Technologies has not fully completed all shipping under its major 19C BARDA contract, though the contract is nearing its end

1 · Reply

nyamsamb Apr. 21 at 2:13 PM

$SIGA Whyee?

0 · Reply

petsaregood71 Apr. 19 at 2:53 PM

$SIGA https://www.the-sun.com/news/16243424/terrorists-weaponise-viruses-smallpox-ebola-biolabs-arms-race/#:~:text=The%20threat%20of%20an%20apocalyptic,extremists%20could%20unleash%20%E2%80%9Cunnatural%E2%80%9D%20pandemics.

0 · Reply

jlonards Apr. 18 at 6:51 PM

$SIGA Thursday will be fun

0 · Reply

LouKojak Apr. 18 at 3:05 AM

$SIGA CDC still recomnends tpoxx for severe cases of monkey pox. Consider use of TPOXX in combination with Brincidofovir for patients with severe immunocompromise or patients at risk of severe disease. To request TPOXX and Brincidofovir for a patient who meets CDC eligibility criteria, contact SFDPH at the phone numbers provided below.

0 · Reply

petsaregood71 Apr. 17 at 5:51 PM

$SIGA They are still using TPOXX for mpox https://www.sf.gov/news-health-alert-san-franciso-reports-first-clade-i-mpox-case

1 · Reply

Why Are Siga Technologies Shares Trading Higher?

Mar 26, 2026, 4:01 PM EDT - 4 weeks ago

SIGA Declares Special Cash Dividend of $0.60 Per Share

Mar 17, 2026, 12:49 PM EDT - 6 weeks ago

Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.

EBS

Mar 10, 2026, 4:30 PM EDT - 7 weeks ago

SIGA Technologies Earnings Call Transcript: Q4 2025

Mar 10, 2026, 4:01 PM EDT - 7 weeks ago

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update

Mar 3, 2026, 7:30 AM EST - 2 months ago

SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results

Nov 6, 2025, 4:30 PM EST - 6 months ago

SIGA Technologies Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:01 PM EST - 6 months ago

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025

Oct 30, 2025, 7:30 AM EDT - 6 months ago

SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results

Sep 1, 2025, 10:52 AM EDT - 8 months ago

7 Big Yields From The Beat-Up Healthcare Sector

BMY DOC LTC OHI PFE SILA

Aug 5, 2025, 4:30 PM EDT - 9 months ago

SIGA Technologies Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:01 PM EDT - 9 months ago

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025

Jul 29, 2025, 7:30 AM EDT - 9 months ago

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

May 8, 2025, 4:30 PM EDT - 1 year ago

SIGA Technologies Earnings Call Transcript: Q1 2025

May 8, 2025, 4:05 PM EDT - 1 year ago

SIGA Reports Financial Results for Three Months Ended March 31, 2025

May 1, 2025, 7:30 AM EDT - 1 year ago

SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results

Mar 18, 2025, 7:30 AM EDT - 1 year ago

SIGA Appoints Retired General John M. Keane to its Board of Directors

Mar 11, 2025, 4:30 PM EDT - 1 year ago

SIGA Technologies Earnings Call Transcript: Q4 2024

Mar 11, 2025, 4:05 PM EDT - 1 year ago

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024

Mar 4, 2025, 7:30 AM EST - 1 year ago

SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results

Jan 2, 2025, 7:30 AM EST - 1 year ago

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

Dec 10, 2024, 4:00 PM EST - 1 year ago

Interim Results from STOMP Study of SIGA's Tecovirimat in Treatment of Mpox Announced

Nov 8, 2024, 9:18 AM EST - 1 year ago

SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman

Nov 7, 2024, 4:30 PM EST - 1 year ago

SIGA Technologies Earnings Call Transcript: Q3 2024

Oct 31, 2024, 7:30 AM EDT - 1 year ago

SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

Oct 23, 2024, 8:17 AM EDT - 1 year ago

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws

Oct 22, 2024, 7:30 AM EDT - 1 year ago

SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

Oct 8, 2024, 7:42 AM EDT - 1 year ago

Siga Technologies to supply mpox therapy in Morocco

Oct 8, 2024, 7:30 AM EDT - 1 year ago

SIGA Announces Agreement to Supply TPOXX® in Morocco

Oct 3, 2024, 12:00 PM EDT - 1 year ago

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

Oct 2, 2024, 3:03 PM EDT - 1 year ago

The Law Offices of Frank R. Cruz Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

Sep 27, 2024, 8:22 AM EDT - 1 year ago

Wolf Haldenstein Adler Freeman & Herz LLP Announces that it is Investigating SIGA Technologies, Inc. for Potential Violations of Federal Securities Laws

Aug 21, 2024, 4:00 PM EDT - 1 year ago

SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®

Aug 16, 2024, 2:17 PM EDT - 1 year ago

Stock Of The Day: Bull Trap Snares SIGA Technologies On Heels Of Mpox Study

Aug 15, 2024, 8:36 AM EDT - 1 year ago

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

EBS GOVX

Aug 15, 2024, 7:35 AM EDT - 1 year ago

Topline Results from PALM 007 Study of SIGA's Tecovirimat in Treatment of Mpox Released

Aug 1, 2024, 4:30 PM EDT - 1 year ago

SIGA Technologies Earnings Call Transcript: Q2 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

SIGA Technologies Earnings Call Transcript: Q1 2024

Mar 12, 2024, 4:30 PM EDT - 2 years ago

SIGA Technologies Earnings Call Transcript: Q4 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

SIGA Technologies Earnings Call Transcript: Q3 2023

Aug 8, 2023, 4:30 PM EDT - 2 years ago

SIGA Technologies Earnings Call Transcript: Q2 2023

May 4, 2023, 4:30 PM EDT - 3 years ago

SIGA Technologies Earnings Call Transcript: Q1 2023

Mar 2, 2023, 4:30 PM EST - 3 years ago

SIGA Technologies Earnings Call Transcript: Q4 2022

Nov 3, 2022, 6:30 AM EDT - 3 years ago

SIGA Technologies Earnings Call Transcript: Q3 2022

Aug 4, 2022, 6:28 AM EDT - 4 years ago

SIGA Technologies Earnings Call Transcript: Q2 2022

May 5, 2022, 3:28 AM EDT - 4 years ago

SIGA Technologies Earnings Call Transcript: Q1 2022

TJCaz Apr. 26 at 2:08 PM

1 · Reply

ComradeKomisar Apr. 23 at 8:11 PM

$SIGA 🤔

1 · Reply

petsaregood71 Apr. 23 at 11:07 AM

$SIGA https://www.futuremarketinsights.com/reports/monkeypox-treatment-market

0 · Reply

Jonnystar Apr. 22 at 1:09 PM

$SIGA time to buy

0 · Reply

petsaregood71 Apr. 21 at 8:02 PM

$SIGA OFF GOOG AI--As of April 2026, SIGA Technologies has not fully completed all shipping under its major 19C BARDA contract, though the contract is nearing its end

1 · Reply

nyamsamb Apr. 21 at 2:13 PM

$SIGA Whyee?

0 · Reply

petsaregood71 Apr. 19 at 2:53 PM

0 · Reply

jlonards Apr. 18 at 6:51 PM

$SIGA Thursday will be fun

0 · Reply

LouKojak Apr. 18 at 3:05 AM

0 · Reply

petsaregood71 Apr. 17 at 5:51 PM

$SIGA They are still using TPOXX for mpox https://www.sf.gov/news-health-alert-san-franciso-reports-first-clade-i-mpox-case

1 · Reply

jlonards Apr. 17 at 2:29 PM

$SIGA

0 · Reply

geniuscali Apr. 15 at 6:01 PM

$SIGA will this ever go back to the teens?

1 · Reply

LouKojak Apr. 14 at 3:35 AM

$SIGA

0 · Reply

jlonards Apr. 14 at 1:53 AM

$SIGA probably the best buy of the 50 stocks I track.

0 · Reply

frankmargo Apr. 9 at 6:29 PM

$SIGA just dont understand. Thought for years this was a fine/reputable company w ron Perlman s backing. Tired of losing. Price now is less than when they came out of bankrupsy. Something is definately wrong. Everthing else has gone up 10 fold since then and this price is at the low

2 · Reply

jlonards Apr. 9 at 4:07 AM

$SIGA strange days indeed

0 · Reply

BiotechGoldenEra Apr. 8 at 5:48 AM

$SIGA so we got mpox

0 · Reply

French_Vibe Apr. 7 at 12:59 PM

$SIGA Thanks to tell the truth, too many pumpers here.

2 · Reply

cubie Apr. 7 at 12:44 PM

$SIGA cubie teaches how dividends affect the prices. 😚

1 · Reply

LouKojak Apr. 7 at 5:28 AM

$SIGA people are panicing to sell 😅😅😅🤑

1 · Reply

LouKojak Apr. 7 at 1:41 AM

$SIGA please announce barda this week 😅

1 · Reply

AloneMask Apr. 6 at 10:41 PM

$SIGA overnight hold for 60c special dividend.

1 · Reply

Market Cap	327.41M
Revenue (ttm)	94.57M
Net Income (ttm)	23.28M
EPS (ttm)	N/A
PE Ratio	14.74
Forward PE	N/A
Profit Margin	24.62%
Debt to Equity Ratio	0.00

Volume	159,488
Avg Vol	706,350
Day's Range	N/A - N/A
Shares Out	71.64M
Stochastic %K	44%
Beta	1.05
Analysts	Strong Buy
Price Target	$11.00